<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02480088</url>
  </required_header>
  <id_info>
    <org_study_id>4-2014-0583</org_study_id>
    <nct_id>NCT02480088</nct_id>
  </id_info>
  <brief_title>Comparison of Palonosetron and Ramosetron for Preventing Patient-controlled Analgesia Related Nausea and Vomiting Following Spine Surgery; Association With ABCB1 Polymorphism</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Yonsei University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Yonsei University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Opioid-based intravenous patient-controlled analgesia (IV-PCA) offers excellent pain control,
      however, its use inevitably increases the incidence of postoperative nausea and vomiting
      (PONV). Ramosetron and palonosetron are commonly used 5-HT3 antagonists for the prevention
      and treatment of PONV. It is not clear which one has superior antiemetic efficacy for the
      prevention of PONV in patients using opioid-based IV-PCA. The antiemetic efficacy of 5HT3
      antagonists may be influenced by polymorphism of ABCB1, a drug-transporter gene. This study
      evaluates relative antiemetic efficacy of ramosetron and palonosetron in patients using
      IV-PCA after spinal surgery and impact of ABCB1 polymorphism on the antiemetic efficacy of
      the ramosetron and palonosetron. The incidence and intensity of PONV during postoperative 48
      h will be assessed. ABCB1 polymorphisms 3435C&gt;T and 2677G&gt;T/A will be evaluated in all
      patients.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">September 22, 2014</start_date>
  <completion_date type="Actual">March 11, 2015</completion_date>
  <primary_completion_date type="Actual">March 11, 2015</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>number of postoperative nausea and vomiting incidence</measure>
    <time_frame>during postoperative 48h</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">300</enrollment>
  <condition>Postoperative Nausea and Vomiting</condition>
  <arm_group>
    <arm_group_label>ramosetron</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>patients receiving ramosetron for prophylaxis of postoperative nausea and vomiting</description>
  </arm_group>
  <arm_group>
    <arm_group_label>palonosetron</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>patients receiving palonosetron for prophylaxis of postoperative nausea and vomiting</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ramosetron</intervention_name>
    <description>ramosetron 0.3 mg IV 20 min before the end of surgery and 24 h after the surgery</description>
    <arm_group_label>ramosetron</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Palonosetron</intervention_name>
    <description>palonosetron 0.075 mg IV 20 min before the end of surgery and 24 h after the surgery.</description>
    <arm_group_label>palonosetron</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients aged 20-85 yr

          -  undergoing spine surgery

        Exclusion Criteria:

          -  Taking steroids or opioids preoperatively

          -  GI motility disorder

          -  Uncontrolled diabetes

          -  Severe renal or hepatic disease

          -  Transfer to ICU postoperatively

          -  Obesity (BMI&gt;35 kg/m2)

          -  Use of antiemetic agent within 24 h preoperatively

          -  Pregnancy

          -  Psychiatric disease

          -  Drug or alcohol abuser

          -  Malignancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Department of Anesthesiology and Pain Medicine and Anesthesia</name>
      <address>
        <city>Seoul</city>
        <zip>120-752</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>October 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 17, 2015</study_first_submitted>
  <study_first_submitted_qc>June 21, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 24, 2015</study_first_posted>
  <last_update_submitted>October 25, 2017</last_update_submitted>
  <last_update_submitted_qc>October 25, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">October 27, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Nausea</mesh_term>
    <mesh_term>Vomiting</mesh_term>
    <mesh_term>Postoperative Nausea and Vomiting</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Palonosetron</mesh_term>
    <mesh_term>Ramosetron</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

